Covid-19 vaccine AstraZeneca

Covid-19 vaccine AstraZeneca

The University of Oxford partnered with the British-Swedish company AstraZeneca to develop and test a coronavirus vaccine known as ChAdOx1 nCoV-19 or AZD1222.

News

 * 04 Mar 2021, Politoco.eu, Italy blocks shipment of Oxford/AstraZeneca vaccine headed to Australia, The EU’s export scheme requires companies to get explicit authorization from national authorities before exporting vaccines.
 * 03 Mar 2021, Politico.eu, Breton: No AstraZeneca jabs exported from the Netherlands after EU export controls, The Dutch site Halix has been a source confusion in the puzzle over why AstraZeneca fell more than 60 million doses short of its pledged EU delivery in the first quarter. The EU has largely blamed AstraZeneca, saying it sent those vaccines to the U.K.
 * 02 Mar 2021, Politico.eu, UK to import vaccine doses from India amid global jabs race, The U.K. will receive its first tranche of 10 million Indian-made Oxford/AstraZeneca doses next week, according to U.K. officials, allowing Britain to speed ahead in vaccinations while less wealthy countries wait.
 * 02 Mar 2021, FDANews.com, EU assessing Serum Institute of India’s AstraZeneca vaccine production
 * 22 Feb 2021, Politico.eu, How the UK gained an edge with AstraZeneca’s vaccine commitments, A comparison of the UK and EU contracts shows that London’s deal has extra teeth.
 * 12 Feb 2021, Politico.eu, After failing to deliver, AstraZeneca rethinks EU coronavirus vaccine supply chain, The British-Swedish drugmaker is signing new manufacturing deals.
 * 10 Feb 2021, Politico.eu, Von der Leyen: ‘Mistakes were made’ on vaccine export ban but ‘we got it right’: "If the United Kingdom is not willing to deliver doses to Europe, then why should we deliver doses to the United Kingdom?" Weber asked.
 * 10 Feb 2021, Politico.eu, Belgian plant blamed for AstraZeneca vaccine shortage says it met all deliveries
 * 10 Feb 2021, Reuters.com, Belgian plant Novasep says it complies with AstraZeneca contract amid vaccine supply cuts: The factory, which U.S. firm Thermo Fisher Scientific acquired from Novasep in January, has been identified as the cause of the cuts by AstraZeneca in internal meetings, several EU officials have said.
 * 03 Feb 2021, Politico.eu, Switzerland won’t authorize Oxford/AstraZeneca vaccine, citing lack of data: Swiss regulators first want to see data from large-scale human trials.
 * 02 Feb 2021, Politico.eu, France, Sweden, Poland: Oxford/AstraZeneca vaccine not for elderly: The French health authority cited insufficient data on the elderly to make a conclusion.
 * 29 Jan 2021, Politico.eu, EU approves Oxford/AstraZeneca vaccine but fails to erase doubts: German scientists stood by their call that there isn’t enough data to know whether use the vaccine in people over 65.
 * 29 Jan 2021, Politico.eu, EU regulator OKs Oxford/AstraZeneca coronavirus vaccine for all adults, The viral vector vaccine was long seen as the front-runner but was delayed after clinical trial issues in the fall.
 * 29 Jan 2021, Politico.eu, Redacted contract fails to clear up EU-AstraZeneca vaccine row, It’s still not clear how many doses the firm committed to provide in the first quarter.
 * 28 Jan 2021, Politico.eu, AstraZeneca’s ‘best efforts’ defense isn’t bulletproof, The phrase is at the heart of a battle over the EU’s delayed vaccine delivery.
 * 27 Jan 2021, Politico.eu, EU commissioner: AstraZeneca logic might work at the butcher’s, but not in vaccine contracts, ‘We reject the logic of first come, first served,’ says Health Commissioner Stella Kyriakides.